Search - tctmd.com

Displaying 361 - 379 of 379

Sort: Relevancy | Date

News Daily News

El Ticagrelor ofrece una Inhibición Plaquetaria Más Potente que el Prasugrel

July 10, 2012

News Daily News

Subanálisis del PLATO: El Ticagrelor es Rentable en Pacientes con SCA

June 26, 2012

News Daily News

PLATO Subanalysis: Ticagrelor Cost-Effective in ACS Patients

June 26, 2012

Presentation

Cost-Effectiveness of Treating ACS Patients with Ticagrelor for 12 Months

Presenter: Elisabet Nikolic

June 25, 2012

News Daily News

Se Publica el GIFT: Confirmado el Papel del CYP2C19 en la Variabilidad de la Respuesta al Clopidogrel

L.A. McKeown

May 23, 2012

News Daily News

GIFT Published: Role of CYP2C19 in Clopidogrel Response Variability Confirmed

L.A. McKeown

May 23, 2012

News Daily News

El Genotipado Rápido a Pie de Cama podría Determinar la Estrategia Antiplaquetaria tras una PCI

Caitlin E. Cox

March 30, 2012

News Daily News

Mejor Respuesta al Clopidogrel a Mayores Niveles de Tabaquismo

Jason Kahn

March 21, 2012

News Daily News

Better Clopidogrel Response Seen with Increased Smoking Levels

Jason Kahn

March 21, 2012

News Daily News

PLATO Analysis: PPIs Problematic with Both Ticagrelor, Clopidogrel

Caitlin E. Cox

March 06, 2012

News Daily News

Análisis PLATO: Los IBP son Problemáticos tanto con el Ticagrelor como con el Clopidogrel

Caitlin E. Cox

March 06, 2012

Presentation

Association of PPI Use and Cardiovascular Outcomes with Clopidogrel and Ticagrelor

Presenter: Shaun G. Goodman

January 24, 2012

Presentation

Relaciones entre el uso de IBP y Desenlaces Cardiovasculares con Clopidogrel y Ticagrelor

Presenter: Shaun G. Goodman

January 24, 2012

News Daily News

First-Year Stent Thombosis Risk High—and Dangerous—in ACS Patients

October 31, 2011

News Daily News

Apixaban Increases Major Bleeding in High-Risk ACS Patients

Jason Kahn

July 25, 2011

News Daily News

Ticagrelor Gains FDA Approval for Use in ACS

Caitlin E. Cox

July 22, 2011

News Daily News

Study Applies Standardized Bleeding Definition to Disparate Antiplatelet Trials

June 15, 2011

News Daily News

Antithrombin Plus Preloading with Clopidogrel May Reduce Stent Thrombosis

L.A. McKeown

April 15, 2011

News Daily News

Ticagrelor More Effective Than Clopidogrel in ACS-With No Extra Bleeding

Kim Dalton

August 30, 2009

Advertisement

El Ticagrelor ofrece una Inhibición Plaquetaria Más Potente que el Prasugrel

Subanálisis del PLATO: El Ticagrelor es Rentable en Pacientes con SCA

PLATO Subanalysis: Ticagrelor Cost-Effective in ACS Patients

Cost-Effectiveness of Treating ACS Patients with Ticagrelor for 12 Months

Se Publica el GIFT: Confirmado el Papel del CYP2C19 en la Variabilidad de la Respuesta al Clopidogrel

GIFT Published: Role of CYP2C19 in Clopidogrel Response Variability Confirmed

El Genotipado Rápido a Pie de Cama podría Determinar la Estrategia Antiplaquetaria tras una PCI

Mejor Respuesta al Clopidogrel a Mayores Niveles de Tabaquismo

Better Clopidogrel Response Seen with Increased Smoking Levels

PLATO Analysis: PPIs Problematic with Both Ticagrelor, Clopidogrel

Análisis PLATO: Los IBP son Problemáticos tanto con el Ticagrelor como con el Clopidogrel

Association of PPI Use and Cardiovascular Outcomes with Clopidogrel and Ticagrelor

Relaciones entre el uso de IBP y Desenlaces Cardiovasculares con Clopidogrel y Ticagrelor

First-Year Stent Thombosis Risk High—and Dangerous—in ACS Patients

Apixaban Increases Major Bleeding in High-Risk ACS Patients

Ticagrelor Gains FDA Approval for Use in ACS

Study Applies Standardized Bleeding Definition to Disparate Antiplatelet Trials

Antithrombin Plus Preloading with Clopidogrel May Reduce Stent Thrombosis

Ticagrelor More Effective Than Clopidogrel in ACS-With No Extra Bleeding

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content